Patient number N (%) | ||||
---|---|---|---|---|
Total | qPCR analysis | ELISA analysis | Chemotaxis | |
Patients | 23(100) | 20(100) | 11(100) | 3(100) |
Male | 15(65) | 14(70) | 6(55) | 1(33) |
Female | 8(35) | 6(30) | 5(45) | 2(67) |
Tumor stage: | ||||
Stage 0 | 4(17) | 4(20) | 2(18) | |
Stage 0is | 1(4) | 1(5) | ||
Stage 1 | 6(26) | 5(25) | 3(27) | 1(33) |
Stage 2 | 2(9) | 2(10) | 1(9) | |
Stage 3 | 8(35) | 6(30) | 4(36) | 2(67) |
Stage 4 | 2(9) | 2(10) | 1(9) | |
Prior treatment: | ||||
None | 15(65) | 13(65) | 7(64) | 2(67) |
BCG | 5(22) | 5(25) | 2(18) | |
Other treatment | 3(13) | 2(10) | 2(18) | 1(33) |